Global Thrombocytopenia (Immune and Chemotherapy-induced) Market to grow at 5.82% CAGR during forecast period (2019-2023) | Size and Share Analysis

Dallas,Texas United States - September 11, 2019 /MarketersMEDIA/ —

The global thrombocytopenia market would witness considerable growth in coming years, due to the rising prevalence of thrombocytopenia and associated risk factors. The most common type of thrombocytopenia is ITP, which is highly prevalent in patients with rheumatoid arthritis. Whereas, CIT (Chemotherapy-Induced Thrombocytopenia) occurs in patients with cancer, due to the involvement of chemotherapy and radiation treatment. Thrombocytopenia in patients with CLD is growing rapidly with an increase in incidences of HCV infections among them.

The global immune thrombocytopenia (ITP) market is expected to reach 2.27 billion in 2023, growing at a CAGR of 5.82%, for the duration spanning 2019-2023. The factors such as, rising healthcare expenditures, growing female population, rising prevalence of arthritis, increasing incidences of hepatitis C and new cases of diagnosed cancer would drive the growth of the market. However, market growth would be challenged by the lethargic drug approval process, side effects associated with available thrombocytopenia drugs and the availability of alternative treatment options. A few notable trends include, novel drug development for thrombocytopenia, increasing number of awareness programs against thrombocytopenia, and increasing preferences for biosimilars.

Request a sample @https://www.orbisresearch.com/contacts/request-sample/3641282

The fastest growing regional market is the U.S., owing to the high prevalence of thrombocytopenia in patients with cancer as well as chronic liver diseases. Moreover, rising awareness about the symptoms and causes of thrombocytopenia among people, through various campaigns and the FDA approvals of various novel drugs for the treatment of thrombocytopenia would drive considerable growth in the global thrombocytopenia market.

Scope of the report:
• The report provides a comprehensive analysis of the global thrombocytopenia (Immune and Chemotherapy-induced) market.
• The major regional market (the U.S.) has been analyzed.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Novartis AG, Merck and Co., CSL Limited, Amgen Pharmaceuticals, Horizon Therapeutics and Rigel Pharmaceuticals) are also presented in detail.

Browse the full report@https://www.orbisresearch.com/reports/index/global-thrombocytopenia-immune-and-chemotherapy-induced-market-insights-trends-and-forecast-2019-2023

Key Target Audience:
• Thrombocytes Drugs Manufacturers
• Chemical Suppliers
• End Users (Hospital, Medical Centers, Clinical Institutes)
• Healthcare Consulting Firms
• Investment Banks
• Government Bodies & Regulating Authorities

Few points from Table of Contents:
1. Overview
1.1 Introduction
1.2 Causes of Thrombocytopenia
1.3 Symptoms of Thrombocytopenia
1.4 Diagnosis of Thrombocytopenia
1.5 Treatment of Thrombocytopenia
1.6 Pathophysiology of Thrombocytopenia

2. Global Thrombocytopenia Market
2.1 Global ITP Market
2.1.1 Global ITP Market Forecast by Value
2.1.2 Global ITP Total Patient Volume Forecast
2.1.3 Global ITP Total Patient Volume Forecast by Region
2.1.4 Global ITP Treated Patient Volume Forecast
2.1.5 Global ITP Treated Patient Volume Forecast by Region
2.2 Global CIT Market
2.2.1 Global CIT Total Patient Volume Forecast
2.2.2 Global CIT Total Patient Volume Forecast by Region
2.2.3 Global CIT Treated Patient Volume Forecast
2.2.4 Global CIT Treated Patient Volume Forecast by Region
Continued…

Direct purchase a single user copy@https://www.orbisresearch.com/contact/purchase-single-user/3641282

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our client’s to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A
Phone: +1 (972)-362-8199
Website: https://www.orbisresearch.com/reports/index/global-thrombocytopenia-immune-and-chemotherapy-induced-market-insights-trends-and-forecast-2019-2023

Release ID: 88918076